Zyceva 150 Zyceva 150 contains Erlotinib 150 mg, a targeted anti-cancer medicine used to treat specific cancers driven by EGFR gene mutations. It works by blocking the signals that help cancer cells grow and spread, thereby slowing the progression of the disease. This medicine is prescribed as part of a personalized treatment plan and should only be used under the supervision of an oncologist.